APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemoperfusion Production

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.

Selected research

Market Outlook & Growth Opportunities

Global Hemoperfusion Production Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchHemoperfusion Production Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoperfusion Production Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Hemoperfusion Production Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoperfusion Production Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoperfusion Production Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.

Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.

Read the full market overview

In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.

This report provides an overview of the global Hemoperfusion Production market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemoperfusion Production and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemoperfusion Production sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemoperfusion Production market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemoperfusion Production Segment by Company

Jafron Biomedical

Baxter (Gambro)

Biosun Medical

Toray Medical

Asahi-Kasei

Kaneka

Zibo Kangbei

Aier

Cytosorbents

Hemoperfusion Production Segment by Type

Resin Adsorption

Activated Carbon Adsorption

Others

Hemoperfusion Production Segment by Application

Overdose

Specific Intoxications

Certain Autoimmune Diseases

Hepatic Encephalopathy

Others

Hemoperfusion Production Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemoperfusion Production status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hemoperfusion Production market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemoperfusion Production significant trends, drivers, influence factors in global and regions.

6. To analyze Hemoperfusion Production competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion Production and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion Production.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemoperfusion Production market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemoperfusion Production industry.

Chapter 3: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hemoperfusion Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hemoperfusion Production in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemoperfusion Production Industry Trends Table 2. Hemoperfusion Production Industry Drivers Table 3. Hemoperfusion Production Industry Opportunities and Challenges Table 4. Hemoperfusion Production Industry Restraints Table 5. Global Hemoperfusion Production Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemoperfusion Production Revenue Share by Company (2021-2026) Table 7. Global Hemoperfusion Production Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hemoperfusion Production Sales Volume Share by Company (2021-2026) Table 9. Global Hemoperfusion Production Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Hemoperfusion Production Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hemoperfusion Production Key Company Manufacturing Base & Headquarters Table 12. Global Hemoperfusion Production Company, Product Type & Application Table 13. Global Hemoperfusion Production Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemoperfusion Production by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Resin Adsorption Table 18. Significant Companies of Activated Carbon Adsorption Table 19. Significant Companies of Others Table 20. Global Hemoperfusion Production Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Hemoperfusion Production Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Hemoperfusion Production Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Hemoperfusion Production Sales Volume Share by Type (2021-2026) Table 24. Global Hemoperfusion Production Sales Volume Share by Type (2027-2032) Table 25. Global Hemoperfusion Production Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hemoperfusion Production Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Hemoperfusion Production Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Hemoperfusion Production Sales Value Share by Type (2021-2026) Table 29. Global Hemoperfusion Production Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Overdose Table 31. Significant Companies of Specific Intoxications Table 32. Significant Companies of Certain Autoimmune Diseases Table 33. Significant Companies of Hepatic Encephalopathy Table 34. Significant Companies of Others Table 35. Global Hemoperfusion Production Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Hemoperfusion Production Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Hemoperfusion Production Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Hemoperfusion Production Sales Volume Share by Application (2021-2026) Table 39. Global Hemoperfusion Production Sales Volume Share by Application (2027-2032) Table 40. Global Hemoperfusion Production Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Hemoperfusion Production Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Hemoperfusion Production Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Hemoperfusion Production Sales Value Share by Application (2021-2026) Table 44. Global Hemoperfusion Production Sales Value Share by Application (2027-2032) Table 45. Global Hemoperfusion Production Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Hemoperfusion Production Sales by Region (2021-2026) & (K Units) Table 47. Global Hemoperfusion Production Sales Market Share by Region (2021-2026) Table 48. Global Hemoperfusion Production Sales by Region (2027-2032) & (K Units) Table 49. Global Hemoperfusion Production Sales Market Share by Region (2027-2032) Table 50. Global Hemoperfusion Production Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Hemoperfusion Production Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Hemoperfusion Production Sales Value Share by Region (2021-2026) Table 53. Global Hemoperfusion Production Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Hemoperfusion Production Sales Value Share by Region (2027-2032) Table 55. Global Hemoperfusion Production Market Average Price (USD/Unit) by Region (2021-2026) Table 56. Global Hemoperfusion Production Market Average Price (USD/Unit) by Region (2027-2032) Table 57. Global Hemoperfusion Production Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Hemoperfusion Production Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hemoperfusion Production Sales by Country (2021-2026) & (K Units) Table 60. Global Hemoperfusion Production Sales Market Share by Country (2021-2026) Table 61. Global Hemoperfusion Production Sales by Country (2027-2032) & (K Units) Table 62. Global Hemoperfusion Production Sales Market Share by Country (2027-2032) Table 63. Global Hemoperfusion Production Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Hemoperfusion Production Sales Value Market Share by Country (2021-2026) Table 65. Global Hemoperfusion Production Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Hemoperfusion Production Sales Value Market Share by Country (2027-2032) Table 67. Jafron Biomedical Company Information Table 68. Jafron Biomedical Business Overview Table 69. Jafron Biomedical Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. Jafron Biomedical Hemoperfusion Production Product Portfolio Table 71. Jafron Biomedical Recent Development Table 72. Baxter (Gambro) Company Information Table 73. Baxter (Gambro) Business Overview Table 74. Baxter (Gambro) Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Baxter (Gambro) Hemoperfusion Production Product Portfolio Table 76. Baxter (Gambro) Recent Development Table 77. Biosun Medical Company Information Table 78. Biosun Medical Business Overview Table 79. Biosun Medical Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Biosun Medical Hemoperfusion Production Product Portfolio Table 81. Biosun Medical Recent Development Table 82. Toray Medical Company Information Table 83. Toray Medical Business Overview Table 84. Toray Medical Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Toray Medical Hemoperfusion Production Product Portfolio Table 86. Toray Medical Recent Development Table 87. Asahi-Kasei Company Information Table 88. Asahi-Kasei Business Overview Table 89. Asahi-Kasei Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Asahi-Kasei Hemoperfusion Production Product Portfolio Table 91. Asahi-Kasei Recent Development Table 92. Kaneka Company Information Table 93. Kaneka Business Overview Table 94. Kaneka Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Kaneka Hemoperfusion Production Product Portfolio Table 96. Kaneka Recent Development Table 97. Zibo Kangbei Company Information Table 98. Zibo Kangbei Business Overview Table 99. Zibo Kangbei Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Zibo Kangbei Hemoperfusion Production Product Portfolio Table 101. Zibo Kangbei Recent Development Table 102. Aier Company Information Table 103. Aier Business Overview Table 104. Aier Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Aier Hemoperfusion Production Product Portfolio Table 106. Aier Recent Development Table 107. Cytosorbents Company Information Table 108. Cytosorbents Business Overview Table 109. Cytosorbents Hemoperfusion Production Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Cytosorbents Hemoperfusion Production Product Portfolio Table 111. Cytosorbents Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Hemoperfusion Production Distributors List Table 115. Hemoperfusion Production Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Hemoperfusion Production Product Image Figure 2. Global Hemoperfusion Production Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hemoperfusion Production Sales (2021-2032) & (K Units) Figure 5. Global Hemoperfusion Production Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Hemoperfusion Production Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Resin Adsorption Image Figure 10. Activated Carbon Adsorption Image Figure 11. Others Image Figure 12. Global Hemoperfusion Production Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Hemoperfusion Production Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Hemoperfusion Production Sales Volume Share by Type (2021-2032) Figure 15. Global Hemoperfusion Production Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Hemoperfusion Production Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Hemoperfusion Production Sales Value Share by Type (2021-2032) Figure 18. Overdose Image Figure 19. Specific Intoxications Image Figure 20. Certain Autoimmune Diseases Image Figure 21. Hepatic Encephalopathy Image Figure 22. Others Image Figure 23. Global Hemoperfusion Production Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Hemoperfusion Production Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Hemoperfusion Production Sales Volume Share by Application (2021-2032) Figure 26. Global Hemoperfusion Production Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hemoperfusion Production Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Hemoperfusion Production Sales Value Share by Application (2021-2032) Figure 29. Global Hemoperfusion Production Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Hemoperfusion Production Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Hemoperfusion Production Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Hemoperfusion Production Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 34. North America Hemoperfusion Production Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Hemoperfusion Production Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Hemoperfusion Production Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 40. South America Hemoperfusion Production Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Hemoperfusion Production Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Hemoperfusion Production Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Hemoperfusion Production Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Hemoperfusion Production Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Hemoperfusion Production Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Resin Adsorption
  • Activated Carbon Adsorption
  • Others
Applications
  • Overdose
  • Specific Intoxications
  • Certain Autoimmune Diseases
  • Hepatic Encephalopathy
  • Others
Companies covered
  • Jafron Biomedical
  • Baxter (Gambro)
  • Biosun Medical
  • Toray Medical
  • Asahi-Kasei
  • Kaneka
  • Zibo Kangbei
  • Aier
  • Cytosorbents

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemoperfusion Production Sales Value (2021-2032)
  4. 1.2.2 Global Hemoperfusion Production Sales Volume (2021-2032)
  5. 1.2.3 Global Hemoperfusion Production Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hemoperfusion Production Market Dynamics
  1. 2.1 Hemoperfusion Production Industry Trends
  2. 2.2 Hemoperfusion Production Industry Drivers
  3. 2.3 Hemoperfusion Production Industry Opportunities and Challenges
  4. 2.4 Hemoperfusion Production Industry Restraints
3 Hemoperfusion Production Market by Company
  1. 3.1 Global Hemoperfusion Production Company Revenue Ranking in 2025
  2. 3.2 Global Hemoperfusion Production Revenue by Company (2021-2026)
  3. 3.3 Global Hemoperfusion Production Sales Volume by Company (2021-2026)
  4. 3.4 Global Hemoperfusion Production Average Price by Company (2021-2026)
  5. 3.5 Global Hemoperfusion Production Company Ranking (2024-2026)
  6. 3.6 Global Hemoperfusion Production Company Manufacturing Base and Headquarters
  7. 3.7 Global Hemoperfusion Production Company Product Type and Application
  8. 3.8 Global Hemoperfusion Production Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hemoperfusion Production Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hemoperfusion Production Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hemoperfusion Production Market by Type
  1. 4.1 Hemoperfusion Production Type Introduction
  2. 4.1.1 Resin Adsorption
  3. 4.1.2 Activated Carbon Adsorption
  4. 4.1.3 Others
  5. 4.2 Global Hemoperfusion Production Sales Volume by Type
  6. 4.2.1 Global Hemoperfusion Production Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemoperfusion Production Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Hemoperfusion Production Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Hemoperfusion Production Sales Value by Type
  10. 4.3.1 Global Hemoperfusion Production Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemoperfusion Production Sales Value by Type (2021-2032)
  12. 4.3.3 Global Hemoperfusion Production Sales Value Share by Type (2021-2032)
5 Hemoperfusion Production Market by Application
  1. 5.1 Hemoperfusion Production Application Introduction
  2. 5.1.1 Overdose
  3. 5.1.2 Specific Intoxications
  4. 5.1.3 Certain Autoimmune Diseases
  5. 5.1.4 Hepatic Encephalopathy
  6. 5.1.5 Others
  7. 5.2 Global Hemoperfusion Production Sales Volume by Application
  8. 5.2.1 Global Hemoperfusion Production Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hemoperfusion Production Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Hemoperfusion Production Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Hemoperfusion Production Sales Value by Application
  12. 5.3.1 Global Hemoperfusion Production Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hemoperfusion Production Sales Value by Application (2021-2032)
  14. 5.3.3 Global Hemoperfusion Production Sales Value Share by Application (2021-2032)
6 Hemoperfusion Production Regional Sales and Value Analysis
  1. 6.1 Global Hemoperfusion Production Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemoperfusion Production Sales by Region (2021-2032)
  3. 6.2.1 Global Hemoperfusion Production Sales by Region: 2021-2026
  4. 6.2.2 Global Hemoperfusion Production Sales by Region (2027-2032)
  5. 6.3 Global Hemoperfusion Production Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hemoperfusion Production Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hemoperfusion Production Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hemoperfusion Production Sales Value by Region (2027-2032)
  9. 6.5 Global Hemoperfusion Production Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hemoperfusion Production Sales Value (2021-2032)
  12. 6.6.2 North America Hemoperfusion Production Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hemoperfusion Production Sales Value (2021-2032)
  15. 6.7.2 Europe Hemoperfusion Production Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hemoperfusion Production Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hemoperfusion Production Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hemoperfusion Production Sales Value (2021-2032)
  21. 6.9.2 South America Hemoperfusion Production Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hemoperfusion Production Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hemoperfusion Production Sales Value Share by Country, 2025 VS 2032
7 Hemoperfusion Production Country-level Sales and Value Analysis
  1. 7.1 Global Hemoperfusion Production Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemoperfusion Production Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hemoperfusion Production Sales by Country (2021-2032)
  4. 7.3.1 Global Hemoperfusion Production Sales by Country (2021-2026)
  5. 7.3.2 Global Hemoperfusion Production Sales by Country (2027-2032)
  6. 7.4 Global Hemoperfusion Production Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hemoperfusion Production Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hemoperfusion Production Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hemoperfusion Production Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hemoperfusion Production Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hemoperfusion Production Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jafron Biomedical
  2. 8.1.1 Jafron Biomedical Company Information
  3. 8.1.2 Jafron Biomedical Business Overview
  4. 8.1.3 Jafron Biomedical Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jafron Biomedical Hemoperfusion Production Product Portfolio
  6. 8.1.5 Jafron Biomedical Recent Developments
  7. 8.2 Baxter (Gambro)
  8. 8.2.1 Baxter (Gambro) Company Information
  9. 8.2.2 Baxter (Gambro) Business Overview
  10. 8.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter (Gambro) Hemoperfusion Production Product Portfolio
  12. 8.2.5 Baxter (Gambro) Recent Developments
  13. 8.3 Biosun Medical
  14. 8.3.1 Biosun Medical Company Information
  15. 8.3.2 Biosun Medical Business Overview
  16. 8.3.3 Biosun Medical Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biosun Medical Hemoperfusion Production Product Portfolio
  18. 8.3.5 Biosun Medical Recent Developments
  19. 8.4 Toray Medical
  20. 8.4.1 Toray Medical Company Information
  21. 8.4.2 Toray Medical Business Overview
  22. 8.4.3 Toray Medical Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Toray Medical Hemoperfusion Production Product Portfolio
  24. 8.4.5 Toray Medical Recent Developments
  25. 8.5 Asahi-Kasei
  26. 8.5.1 Asahi-Kasei Company Information
  27. 8.5.2 Asahi-Kasei Business Overview
  28. 8.5.3 Asahi-Kasei Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Asahi-Kasei Hemoperfusion Production Product Portfolio
  30. 8.5.5 Asahi-Kasei Recent Developments
  31. 8.6 Kaneka
  32. 8.6.1 Kaneka Company Information
  33. 8.6.2 Kaneka Business Overview
  34. 8.6.3 Kaneka Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kaneka Hemoperfusion Production Product Portfolio
  36. 8.6.5 Kaneka Recent Developments
  37. 8.7 Zibo Kangbei
  38. 8.7.1 Zibo Kangbei Company Information
  39. 8.7.2 Zibo Kangbei Business Overview
  40. 8.7.3 Zibo Kangbei Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zibo Kangbei Hemoperfusion Production Product Portfolio
  42. 8.7.5 Zibo Kangbei Recent Developments
  43. 8.8 Aier
  44. 8.8.1 Aier Company Information
  45. 8.8.2 Aier Business Overview
  46. 8.8.3 Aier Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Aier Hemoperfusion Production Product Portfolio
  48. 8.8.5 Aier Recent Developments
  49. 8.9 Cytosorbents
  50. 8.9.1 Cytosorbents Company Information
  51. 8.9.2 Cytosorbents Business Overview
  52. 8.9.3 Cytosorbents Hemoperfusion Production Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cytosorbents Hemoperfusion Production Product Portfolio
  54. 8.9.5 Cytosorbents Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemoperfusion Production Value Chain Analysis
  2. 9.1.1 Hemoperfusion Production Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemoperfusion Production Sales Mode & Process
  6. 9.2 Hemoperfusion Production Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemoperfusion Production Distributors
  9. 9.2.3 Hemoperfusion Production Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst